The price of paliperidone palmitate in the Philippines can vary significantly based on several factors, including the specific dosage, manufacturer, and the pharmacy where it is purchased. As an antipsychotic medication used for schizophrenia and schizoaffective disorder, its cost is influenced by its patented status and market competition.
How much does paliperidone palmitate typically cost in the Philippines?
While precise pricing fluctuates, available information suggests that a single injection of paliperidone palmitate can range from approximately PHP 15,000 to PHP 30,000 or more [1]. This cost reflects the specialized nature of long-acting injectable medications. For instance, a 3-month supply could potentially cost upwards of PHP 50,000 [1]. These figures are estimates and can differ between healthcare providers and retail pharmacies.
What influences the price of paliperidone palmitate?
The price of paliperidone palmitate is largely determined by its drug patent status and the exclusivity period granted to the innovator company. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can provide insights into when market exclusivity might end and generic competition could potentially emerge, influencing pricing [2]. The dosage strength and the quantity of medication in a package also directly affect the overall price. Furthermore, the distribution channels and any markups by intermediaries contribute to the final cost to the consumer.
Are there different brands of paliperidone palmitate available?
Paliperidone palmitate is primarily marketed under brand names such as Invega Sustenna and Invega Trinza by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [3]. Invega Sustenna is typically administered monthly, while Invega Trinza is a longer-acting formulation administered every three months [3]. The availability of authorized generics or biosimilars in the Philippines could eventually impact pricing, though this is dependent on patent expirations and regulatory approvals.
When might generic paliperidone palmitate become available in the Philippines?
The timeline for the availability of generic versions of paliperidone palmitate depends on patent expirations and any subsequent regulatory approvals for generic manufacturers. Information on specific patent expiry dates for paliperidone palmitate in different regions, including the Philippines, can be found through resources like DrugPatentWatch.com [2]. Generic entry typically leads to a reduction in drug prices.
Does health insurance cover the cost of paliperidone palmitate in the Philippines?
Coverage for paliperidone palmitate by health insurance in the Philippines can vary depending on the specific insurance plan. Many comprehensive health plans may cover the cost of prescription medications, including specialized treatments like long-acting injectables, subject to co-payments, deductibles, and prior authorization requirements [4]. Patients are advised to consult directly with their insurance providers to understand their specific benefits and coverage details for paliperidone palmitate.
Sources:
[1] https://www.drugprice.ph/paliperidone-palmitate-price-philippines/
[2] https://drugpatentwatch.com/
[3] https://www.janssen.com/asia-pacific/our-products
[4] https://www.philamlife.com/en/our-products/health-insurance